ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
Dublin, Ireland, July 22, 2020
ICON Reports Second Quarter 2020 Results
Quarter 2 reported revenue of $620.2 million representing a year on year decrease of 10.8% or 10.3% on a constant currency basis.
ICON plc to Present at Jefferies Virtual Healthcare Conference
Tuesday, June 2, 2020
ICON plc to Present at UBS Virtual Global Healthcare Conference
Wednesday, May 20, 2020
ICON appoints new Chief Medical Officer
ICON announces the appointment of Dr Kristen Buck as the new Chief Medical Officer (CMO).
ICON Reports First Quarter 2020 Results
Reported revenue of $715.1 million representing a 6.0% YoY increase or 6.5% on a constant currency basis. Net business wins of $867 million; a book to bill of 1.21.
ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row
ICON recognised for specialised services offering across product development lifecycle, winning five awards overall.
ICON signs new Service Agreement with Pfizer
Agreement builds on the companies' existing relationship, under which ICON provides global expertise in the planning, execution, management and conduct of clinical trials.
ICON launches the Coronavirus Observatory
The Coronavirus Observatory applies powerful AI analysis and data visualisation to COVID-19 news and social media, providing updates on the latest vaccine trials.
ICON plc to Present at Barclays Global Healthcare Conference 2020
The presentation will be webcast live from 10.15am EDT, Tuesday, March 10, 2020.